Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 1/2 1

Status

Completed 5

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 96Rectal Neoplasms 42Colonic Neoplasms 38Stomach Neoplasms 31Pancreatic Neoplasms 31Neoplasm Metastasis 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Neoplasms 21Esophageal Neoplasms 19Burkitt Lymphoma 15Adenocarcinoma Of Esophagus 14Lymphoma 13Leukemia 8Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Osteosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Biphenotypic, Acute 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Hepatocellular 4Liver Neoplasms 3Intestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

pembrolizumab 120Cisplatin 26Carboplatin 24Paclitaxel 21Docetaxel 17lenvatinib 15Pemetrexed 12Fluorouracil 12Saline Solution 11Capecitabine 10epacadostat 8Oxaliplatin 7Gemcitabine 7Leucovorin 5Cetuximab 5130-nm albumin-bound paclitaxel 5olaparib 4enzalutamide 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4trifluridine tipiracil drug combination 3regorafenib 3Prednisone 3Dexamethasone 3Radiotherapy 2Ipilimumab 2Glucose 2Etoposide 2Doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Parkinson Disease 4, Autosomal Dominant Lewy Body × Leucovorin × Clear all
NCT03221426 2026-03-09

KEYNOTE-585

Merck Sharp & Dohme LLC

Phase 3 Completed
1,007 enrolled 25 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT04882241 2026-03-06

KEYNOTE-585

Merck Sharp & Dohme LLC

Phase 3 Completed
120 enrolled 17 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT02720068 2025-05-30

MK-4280-001

Merck Sharp & Dohme LLC

Phase 1 Completed
481 enrolled 36 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Neoplasms

NCT03374254 2024-11-21

KEYNOTE-651

Merck Sharp & Dohme LLC

Phase 1 Completed
116 enrolled 18 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Spinocerebellar Degenerations, Colorectal Neoplasms

NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Ludwig Institute for Cancer Research

Phase 1/2 Completed
73 enrolled 18 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡